Maternal vitamin D in pregnancy and offspring bone measures in childhood: The Vitamin D in Pregnancy study.


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
07 2019
Historique:
received: 07 11 2018
revised: 29 03 2019
accepted: 23 04 2019
pubmed: 28 4 2019
medline: 30 7 2020
entrez: 28 4 2019
Statut: ppublish

Résumé

Previously we have demonstrated an association between maternal serum 25-hydroxyvitamin D (25(OH)D) during pregnancy and knee-heel length in offspring at birth. However, it is unknown whether maternal serum 25(OH)D is associated with bone measures in childhood. Thus, we aimed to examine associations between 25(OH)D at two stages of pregnancy and offspring bone measures at 11 years. Women were recruited from a single antenatal clinic in Victoria, Australia before 16 weeks gestation and provided two serum samples to determine 25(OH)D status at recruitment and 28-32 weeks gestation. Children and their mothers were followed up at 11 years of age. Children undertook dual energy X-ray absorptiometry scans at the lumbar spine and total body. Maternal 25(OH)D at recruitment (before 16 weeks gestation) was positively associated with the children's bone mineral content and density in boys, but not girls. In boys, a 10 nmol/L (4 ng/mL) increase in maternal 25(OH)D was associated with a median 0.5 g (95% CI 0.1,0.8) and 0.009 g/cm

Identifiants

pubmed: 31028958
pii: S8756-3282(19)30149-8
doi: 10.1016/j.bone.2019.04.013
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-131

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Natalie K Hyde (NK)

Deakin University, Geelong, Victoria, Australia. Electronic address: nhyde@barwonhealth.org.au.

Sharon L Brennan-Olsen (SL)

Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St Albans, Victoria, Australia; Department of Medicine-Western Health, The University of Melbourne, St Albans, Victoria, Australia.

Mohammadreza Mohebbi (M)

Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Victoria, Australia.

John D Wark (JD)

Bone and Mineral Medicine and University of Melbourne Department of Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Sarah M Hosking (SM)

Deakin University, Geelong, Victoria, Australia.

Julie A Pasco (JA)

Deakin University, Geelong, Victoria, Australia; Department of Medicine-Western Health, The University of Melbourne, St Albans, Victoria, Australia; Barwon Health, Geelong, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH